abstract |
A compound (formula (I)) which is arylimidazolyl isoxazole, or a pharmaceutically acceptable salt thereof. The compound has an effect of modulating the activity of p300 and / or CBP, and is used for treating cancer, particularly prostate cancer. [Selection diagram] None |